Suzhou Basecare Medical Corp. Ltd. Class H (HK:2170) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Suzhou Basecare Medical Corp. Ltd. has received approval from China’s National Medical Products Administration to renew the registration of its innovative PGT-A kit until 2030. This renewal underscores the kit’s proven clinical efficacy, having demonstrated 100% concordance in over 100,000 clinical samples. The PGT-A kit is a significant advancement in the field of genetic testing in China, providing accurate analysis for embryo implantation decisions.
For further insights into HK:2170 stock, check out TipRanks’ Stock Analysis page.